Dermatology News and Research

Latest Dermatology News and Research

Merz presents XEOMIN clinical data on dystonia at IDS 2011

New data presented at recent neurological congresses and summarized at the IDS indicate that patients treated with XEOMIN for cervical dystonia or blepharospasm (involuntary closing of the eyelids) experienced long-term sustained efficacy with a favorable safety profile in studies of up to 121 and 88 weeks duration, respectively.

22 Oct 2011

State roundup: Md. program poised for health reform; Calif. high-risk pool; huge insurance premium jump in La. district

Its accountable care organizations will be called coordinated care organizations. And, instead of just aiming to cut costs and increase the quality of care, Oregon wants to actually grade them.

21 Oct 2011

IRIDEX introduces optional MicroPulse module

IRIDEX Corporation announced today that it has expanded its product offering by introducing an optional MicroPulse module in the Company's IQ532 (green) laser system and now provides a complete portfolio of infrared, yellow and green laser systems which can deliver MicroPulse laser treatments.

19 Oct 2011

Positive results from Roche's Phase 3 HannaH trial for HER2-positive early breast cancer

Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the diabetes, cancer, dermatology and drug delivery markets, today announced that the Phase 3 HannaH trial, conducted by Roche, showed that women with HER2-positive early breast cancer who received a new, investigational subcutaneous (SC) injection of Herceptin (trastuzumab), experienced comparable results to Herceptin given as an intravenous infusion.

18 Oct 2011

GeneDx launches new genetic test to accurately diagnose rare diseases

At the joint conference of the American Society of Human Genetics/International Congress on Human Genetics in Montreal on October 12, GeneDx, one of the foremost genetics laboratories in the world and a subsidiary of Bio-Reference Laboratories, Inc., is announcing a first-of-its-kind test that will enable physicians and patients to more accurately identify the genetic cause of rare diseases.

13 Oct 2011

Vitamin D plays an essential role in the body's fight against TB

Not just important for building strong bones, an international team of scientists has found that vitamin D also plays an essential role in the body's fight against infections such as tuberculosis.

12 Oct 2011

AIM at Melanoma applauds bill banning children from using indoor tanning beds

AIM at Melanoma, the largest international foundation dedicated to melanoma research and patient advocacy, applauds Governor Jerry Brown's signing today of Senate Bill 746, which now bans children under 18 from using indoor tanning beds. Tanning beds have been linked to the rapid rise in melanoma rates among 15-39 year olds.

10 Oct 2011

AAD applauds California for prohibiting indoor tanning device use among youngsters

Today California Governor Edmund G. Brown signed a bill into law that will prohibit the use of indoor tanning devices for all Californians under the age of 18.

10 Oct 2011

Vitamin D deficiency might be common in fair skinned people: Study

The British study suggests that pale people tend to be deficient in the “sunshine” vitamin and that without supplements they're unlikely to get their levels up without getting sunburned. That can put them at risk for bone loss, heart disease, and poorer survival from breast cancer, according to the study's authors.

5 Oct 2011

Creabilis receives $20 million in Series B funding

Creabilis SA, a clinical stage European biotechnology company addressing unmet medical needs in dermatology, inflammation and pain, has raised €15 million ($20 million) in a Series B funding round led by Abbott Biotech Ventures.

4 Oct 2011

MDC Partners acquires majority stake in Concentric Pharma

Concentric Pharma Advertising, one of the largest and fastest-growing healthcare advertising agencies in the country, announced today that MDC Partners, Inc., has acquired a majority stake in the company.

1 Oct 2011

New technique helps identify how RNA molecules control gene expression

A new technique developed by researchers at the Stanford University School of Medicine allows researchers to identify the exact DNA sequences and locations bound by regulatory RNAs. This information is necessary to understand how the recently identified RNA molecules control the expression of neighboring and distant genes.

30 Sep 2011

Invida, Sinclair IS launch two dermatology products in seven Asia-Pacific markets

Sinclair IS Pharma Plc, the international specialty pharmaceutical company, and Invida Holdings Private Limited, a leader in the commercialisation of specialty biopharmaceutical and healthcare products throughout Asia Pacific, announce that their partnership has already led to the launch of two Sinclair IS dermatology products in seven Asia-Pacific markets.

30 Sep 2011

Scientists discover effective target to kill late-stage metastatic prostate cancer cells

Purdue University scientists believe they have found an effective target for killing late-stage, metastatic prostate cancer cells.

29 Sep 2011

Valeant's colesevelam New Drug Submission for hypercholesterolemia receives Canadian approval

Valeant Pharmaceuticals International, Inc. announced that its wholly owned subsidiary, Valeant International (Barbados) SRL, has received notice that the New Drug Submission for colesevelam hydrochloride (colesevelam), an oral bile acid sequestrant for hypercholesterolemia, has been approved by the Canadian regulatory authority Health Canada.

28 Sep 2011

Halozyme commences HTI-501 clinical trial for cellulite in women

Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the diabetes, cancer, dermatology and drug delivery markets, today announced the commencement of a Phase 1/2 clinical trial with HTI-501 (rHuCAT-L) in women with moderate to severe edematous fibrosclerotic panniculopathy (also known as cellulite).

28 Sep 2011

Dynatronics fourth quarter sales increase 3% to $8,190,382

Dynatronics Corporation today announced results for its fiscal fourth quarter and year ended June 30, 2011.

28 Sep 2011

Photocure, Ipsen partner to commercialise Hexvix for diagnosis of bladder cancer

Ipsen announces today a partnership with Photocure, a specialty pharmaceutical company focused on photodynamic technologies in cancer and dermatology.

27 Sep 2011

Hair loss, divorce and smoking in women – links established

A new study showed that genetics aside, the next strongest predictor of midline (central) hair loss among women is their marital status, with the loss of a spouse (through either divorce or death) raising the risk for thinning hair above that of married or single women.

26 Sep 2011

S-equol improve appearance of crow's feet skin wrinkles in Japanese menopausal women

A soy germ-based nutritional supplement containing Natural S-equol significantly improved the appearance of crow's feet skin wrinkles of the outer corner of the eyes in Japanese menopausal women, suggesting that supplements containing Natural S-equol have potential to slow skin aging, according to data from a controlled pilot study simultaneously published online in the peer-review journal Menopause and presented in a poster session at the North American Menopause Society annual meeting.

22 Sep 2011

Dermatology News and Research

Latest Dermatology News and Research

Merz presents XEOMIN clinical data on dystonia at IDS 2011

State roundup: Md. program poised for health reform; Calif. high-risk pool; huge insurance premium jump in La. district

IRIDEX introduces optional MicroPulse module

Positive results from Roche's Phase 3 HannaH trial for HER2-positive early breast cancer

GeneDx launches new genetic test to accurately diagnose rare diseases

Vitamin D plays an essential role in the body's fight against TB

AIM at Melanoma applauds bill banning children from using indoor tanning beds

AAD applauds California for prohibiting indoor tanning device use among youngsters

Vitamin D deficiency might be common in fair skinned people: Study

Creabilis receives $20 million in Series B funding

MDC Partners acquires majority stake in Concentric Pharma

New technique helps identify how RNA molecules control gene expression

Invida, Sinclair IS launch two dermatology products in seven Asia-Pacific markets

Scientists discover effective target to kill late-stage metastatic prostate cancer cells

Valeant's colesevelam New Drug Submission for hypercholesterolemia receives Canadian approval

Halozyme commences HTI-501 clinical trial for cellulite in women

Dynatronics fourth quarter sales increase 3% to $8,190,382

Photocure, Ipsen partner to commercialise Hexvix for diagnosis of bladder cancer

Hair loss, divorce and smoking in women – links established

S-equol improve appearance of crow's feet skin wrinkles in Japanese menopausal women

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Dermatology News and Research

Latest Dermatology News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in